Executives Buy More Than $1B Of 4 Stocks - Cytek Biosciences (NASDAQ:CTKB), Clearwater Analytics Hldg (NY

Although US stock futures traded lower this morning on Thursday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Procore Technologies

The Trade: Procore Technologies, Inc. (NYSE:PCOR) Director William J.G. Griffith acquired a total of 1,173,958 shares at an average price of $50.88. To acquire these shares, it cost around $59.73 million.
What’s Happening: Procore Technologies reported its launch in France as part of continued global expansion and growth.
What Procore Technologies Does: Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products.

Occidental Petroleum

The Trade: Occidental Petroleum Corporation (NYSE:OXY) 10% owner Warren E Buffett acquired a total of 18,102,616 shares at an average price of $54.41. To acquire these shares, it cost around $984.96 million.
What’s Happening: Morgan Stanley, on Monday, downgraded Occidental Petroleum from Overweight to Equal-Weight.
What Occidental Petroleum Does: Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East.

Also check this: Alphabet And 4 Other Stocks Sold By Insiders

Cytek Biosciences

The Trade: Cytek Biosciences, Inc. (NASDAQ:CTKB) Director Rajeev Shah bought a total of 583,870 shares at an average price of $12.31. To acquire these shares, it cost around $7.19 million.
What’s Happening: The company, last month, posted upbeat quarterly sales.
What Cytek Biosciences Does: Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches.

Clearwater Analytics Holdings

The Trade: Clearwater Analytics Holdings, Inc. (NYSE:CWAN) 10% owner Durable Capital Partners Lp bought a total of 498,113 shares at an average price of $16.98. The insider spent around $8.46 million to buy those shares.
What’s Happening: Clearwater Analytics recently reported Q4 earnings results and issued guidance.
What Clearwater Analytics Holdings Does: Clearwater Analytics Holdings Inc provides investment accounting and reporting, performance measurement, compliance monitoring, and risk analytics solutions for asset managers, insurance companies, and large corporations.

CTKBCytek Biosciences Inc

$4.00-0.87%

Overview

CWANClearwater Analytics Holdings Inc

$24.35-0.16%

OXYOccidental Petroleum Corp

$55.94-2.68%

PCORProcore Technologies Inc

$44.89-5.32%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.